|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 747791-747815 of 2348685 (93948 Page(s) Totally)
<< < 29907 29908 29909 29910 29911 29912 29913 29914 29915 29916 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
1993 |
Sectorial Measure with Applications to Noneuclidean Trigonometries
|
詹進吉; Dzan, Jin-Jee |
| 國立臺灣大學 |
2009 |
Sectorial-beam dielectric resonator antenna for WiMAX with bent ground plane
|
Chang, Tze-Hsuan; Kiang, Jean-Fu |
| 臺大學術典藏 |
2020-06-11T06:13:26Z |
Sectorial-beam dielectric resonator antenna for WiMAX with bent ground plane
|
Chang, T.-H.;Kiang, J.-F.; Chang, T.-H.; Kiang, J.-F.; JEAN-FU KIANG |
| 國立交通大學 |
2014-12-08T15:34:48Z |
Sectorization with Beam Pattern Design Using 3D Beamforming Techniques
|
Lee, Chang-Shen; Lee, Ming-Chun; Huang, Chung-Jung; Lee, Ta-Sung |
| 國立臺灣大學 |
2001 |
Sectorization, Channel Assignment and Transmission Power Control in Wireless Communications Networks
|
Lin, C.H.; Lin, F.Y.S. |
| 臺北醫學大學 |
2011 |
Sectral 400mgtab 心施德 錠
|
藥劑部藥師 |
| 正修科技大學 |
2009 |
Secu Tech Expo 2009 台北國際安全博覽會
|
謝隆斌 |
| 臺大學術典藏 |
2021-10-28T07:11:17Z |
Secukinumab 2-weekly vs. 4-weekly dosing in plaque-type psoriasis
|
TSEN-FANG TSAI |
| 國立臺灣大學 |
2016 |
Secukinumab delivers greater improvement in health-related quality of life compared to ustekinumab in subjects with moderate to severe plaque psoriasis: 16-week data from the CLEAR study
|
Rubel, D.; Thaci, D.; Blauvelt, A.; Reich, K.; Tsai, T. F.; Vanaclocha, F.; Kingo, K.; Ziv, M.; Pinter, A.; Hugot, S.; You, R.; Augustin, M.; Milutinovic, M.; 蔡呈芳 |
| 國立臺灣大學 |
2015 |
Secukinumab demonstrates an acceptable safety profile in moderate to severe plaque psoriasis: Pooled analysis of 10 phase 2/3 studies
|
Griffiths, Christopher; Reich, Kristian; Leonard, Craig; Blauvelt, Andrew; Mehta, Nehal; Tsai, Tsen-Fang; Gong, Yankun; Huang, Jiaqing; Fox, Todd; 蔡呈芳 |
| 國立臺灣大學 |
2016 |
Secukinumab demonstrates an acceptable safety profile in moderate to severe plaque psoriasis: Pooled analysis of 10 phase 2/3 studies
|
Foley, P.; Griffiths, C.; Reich, K.; Leonardi, C. L.; Blauvelt, A.; Mehta, N. N.; Tsai, T. F.; Gong, Y.; Papavassilis, C.; Huang, J.; Fox, T.; van de Kerkhof, P.; 蔡呈芳 |
| 臺大學術典藏 |
2019-09-16T09:25:16Z |
Secukinumab demonstrates superior efficacy and a faster response in clearing skin in Asian subjects with moderate to severe plaque psoriasis compared with ustekinumab: Subgroup analysis from the CLEAR study
|
Dee, Cathleen Michelle A.;Lee, Joo Heung;Guana, Adriana;Lee, Seung Chul;Huang, Yu Huei;Lee, Min Geol;Aw, Derrick Chen Wee;Bao, Weibin;Kim, Tae Gyun;TSEN-FANG TSAI; TSEN-FANG TSAI; Kim, Tae Gyun; Bao, Weibin; Aw, Derrick Chen Wee; Lee, Min Geol; Huang, Yu Huei; Lee, Seung Chul; Guana, Adriana; Lee, Joo Heung; Dee, Cathleen Michelle A. |
| 臺大學術典藏 |
2020-10-22T07:27:41Z |
Secukinumab demonstrates superior efficacy and a faster response in clearing skin in Asian subjects with moderate to severe plaque psoriasis compared with ustekinumab: Subgroup analysis from the CLEAR study
|
Dee C.M.A.; Guana A.; TSEN-FANG TSAI; Bao W.; Aw D.C.-W.; Kim T.-G.; Lee S.-C.; Lee J.-H.; Huang Y.-H.; Lee M.-G. |
| 中山醫學大學 |
2020 |
Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation With Active Ankylosing Spondylitis: Four-Year Results From a Phase 3 Study, MEASURE 1
|
Tseng, JC; Wei, JCC; Deodhar, A; Martin, R; Porter, B; McCreddin, S; Talloczy, Z |
| 臺大學術典藏 |
2019 |
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study
|
Tha?I D.;Puig L.;Reich K.;Tsen-Fang Tsai;Tyring S.;Kingo K.;Ziv M.;Pinter A.;Vender R.;Lacombe A.;Xia S.;Bhosekar V.;Gilloteau I.;Guana A.;Blauvelt A.; Tha?i D.; Puig L.; Reich K.; TSEN-FANG TSAI; Tyring S.; Kingo K.; Ziv M.; Pinter A.; Vender R.; Lacombe A.; Xia S.; Bhosekar V.; Gilloteau I.; Guana A.; Blauvelt A. |
| 國立臺灣大學 |
2015 |
Secukinumab efficacy and safety in Asian subjects with moderate to severe plaque psoriasis: Pooled analysis from the FIXTURE and ERASURE phase III clinical studies
|
Lee, Jeung-Hoon; Morita, Akimichi; Tsai, Tsen-Fang; Zheng, Eugene; Ko, Luke; Fox, Todd; Langley, Richard; 蔡呈芳 |
| 臺大學術典藏 |
2020-07 |
Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment
|
TSEN-FANG TSAI; Tsen-Fang Tsai |
| 國立臺灣大學 |
2014 |
Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
|
Langley, Richard G.; Elewski, Boni E.; Lebwohl, Mark; Reich, Kristian; Griffiths, Christopher E. M.; Papp, Kim; Puig, Lluis; Nakagawa, Hidemi; Spelman, Lynda; Sigurgeirsson, Bardur; Rivas, Enrique; Tsai, Tsen-Fang; Wasel, Norman; Tyring, Stephen; Salko, Thomas; Hampele, Isabelle; Notter, Marianne; Karpov, Alexander; Helou, Silvia; Papavassilis, Charis; 蔡呈芳 |
| 臺大學術典藏 |
2018-09-10T15:02:46Z |
Secukinumab in plaque psoriasis - Results of two phase 3 trials
|
Langley, R.G. and Elewski, B.E. and Lebwohl, M. and Reich, K. and Griffiths, C.E.M. and Papp, K. and Puig, L. and Nakagawa, H. and Spelman, L. and Sigurgeirsson, B. and Rivas, E. and Tsai, T.-F. and Wasel, N. and Tyring, S. and Salko, T. and Hampele, I. and Notter, M. and Karpov, A. and Helou, S. and Papavassilis, C.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:28:03Z |
Secukinumab in plaque psoriasis - Results of two phase 3 trials
|
Karpov A.; Hampele I.; Notter M.; Salko T.; Tyring S.; Langley R.G.; Elewski B.E.; Lebwohl M.; Reich K.; Griffiths C.E.M.; Papp K.; Puig L.; Nakagawa H.; Spelman L.; Sigurgeirsson B.; Rivas E.; TSEN-FANG TSAI; Wasel N.; Helou S.; Papavassilis C. |
| 臺大學術典藏 |
2018-09-10T18:07:35Z |
Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
|
Wang, T.-S. and Chan, C.-C. and Chiu, H.-Y. and Tsai, T.-F.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2017 |
Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
|
Wang T.-S.;Chan C.-C.;Chiu H.-Y.;Tsen-Fang Tsai; Wang T.-S.; Chan C.-C.; Chiu H.-Y.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2022-01-11T06:49:36Z |
Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
|
Wang T.-S.; Chan C.-C.; HSIEN-YI CHIU; Tsai T.-F. |
| 國立臺灣大學 |
2014 |
Secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the Efficacy of Response and Safety of 2 fixed secUkinumab REgimens in psoriasis (ERASURE)
|
Elewski, B.; Lebwohl, M.; Papp, K.; Nakagawa, H.; Sigurgeirsson, B.; Tsai, T. -F.; Tyring, S.; Hampele, I.; Karpov, A.; Helou, S.; Papavassilis, C.; 蔡呈芳 |
| 臺大學術典藏 |
2020-10-22T07:27:58Z |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
|
Tha?i D.; Blauvelt A.; Reich K.; TSEN-FANG TSAI; Vanaclocha F.; Kingo K.; Ziv M.; Pinter A.; Hugot S.; You R.; Milutinovic M. |
Showing items 747791-747815 of 2348685 (93948 Page(s) Totally)
<< < 29907 29908 29909 29910 29911 29912 29913 29914 29915 29916 > >>
View [10|25|50] records per page
|
